Its role as a regulator of ErbB3 makes EBP1 a contributor to breast cancer progression and treatment resistance, as it controls, for example, the ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells. This evidence concerns the gene ERBB2 and breast cancer.